These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15855722)

  • 1. The frequency of candidate alleles for CYP2D6 genotyping in the Japanese population with an additional respect to the -1584C to G substitution.
    Ikenaga Y; Fukuda T; Fukuda K; Nishida Y; Naohara M; Maune H; Azuma J
    Drug Metab Pharmacokinet; 2005 Apr; 20(2):113-6. PubMed ID: 15855722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients.
    Dorado P; Peñas-LLedó EM; de la Rubia A; LLerena A
    Pharmacogenomics; 2009 Jul; 10(7):1083-9. PubMed ID: 19604081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2D6 -1584C>G promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers.
    Llerena A; Dorado P; Ramírez R; Calzadilla LR; Peñas-Lledó E; Álvarez M; Naranjo ME; González I; Pérez B;
    Pharmacogenomics; 2013 Dec; 14(16):1973-7. PubMed ID: 24279852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CYP2D6 impaired functional alleles in Mexican Americans.
    Luo HR; Gaedigk A; Aloumanis V; Wan YJ
    Eur J Clin Pharmacol; 2005 Dec; 61(11):797-802. PubMed ID: 16283274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CYP2D6 deletion, multiplication, -1584C-->G, 31G-->A and 2988G-->a gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos.
    Sosa-Macías M; Dorado P; Alanis-Bañuelos RE; Llerena A; Lares-Asseff I
    Pharmacology; 2010; 86(1):30-6. PubMed ID: 20588073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population.
    Mitsunaga Y; Kubota T; Ishiguro A; Yamada Y; Sasaki H; Chiba K; Iga T
    Mutat Res; 2002 Aug; 505(1-2):83-5. PubMed ID: 12175908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-step assays to analyze CYP2D6 gene polymorphisms in Asians: allele frequencies and a novel *14B allele in mainland Chinese.
    Ji L; Pan S; Marti-Jaun J; Hänseler E; Rentsch K; Hersberger M
    Clin Chem; 2002 Jul; 48(7):983-8. PubMed ID: 12089164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique Genotyping Protocol of CYP2D6 Allele Frequency Using Real Time Quantitative PCR from Japanese Healthy Women.
    Kisoi M; Imai M; Yamamura M; Sakaguchi Y; Murata S; Ichikawa A; Kinoshita K
    Biol Pharm Bull; 2020; 43(5):904-907. PubMed ID: 32378566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
    Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
    Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.
    Kubota T; Yamaura Y; Ohkawa N; Hara H; Chiba K
    Br J Clin Pharmacol; 2000 Jul; 50(1):31-4. PubMed ID: 10886115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes.
    Byeon JY; Kim YH; Lee CM; Kim SH; Chae WK; Jung EH; Choi CI; Jang CG; Lee SY; Bae JW; Lee YJ
    Arch Pharm Res; 2018 Sep; 41(9):921-930. PubMed ID: 30191460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Minor Haplotypes of CYP2D6 in the Japanese Population.
    Masuda M; Fujiwara T; Matsunaga M; Matsumaru T
    Drug Metab Lett; 2017 Nov; 11(1):53-59. PubMed ID: 28606035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events.
    Toscano C; Klein K; Blievernicht J; Schaeffeler E; Saussele T; Raimundo S; Eichelbaum M; Schwab M; Zanger UM
    Pharmacogenet Genomics; 2006 Oct; 16(10):755-66. PubMed ID: 17001295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis.
    Nishimura M; Ueda M; Saruwatari J; Nakashima H; Ogusu N; Aoki A; Tsuchimine S; Matsuda K; Iwashita K; Ono T; Oniki K; Shimoda K; Yasui-Furukori N
    Pharmacogenet Genomics; 2016 Sep; 26(9):403-13. PubMed ID: 27187662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-based CYP2D6 genotyping in the Korean population.
    Lee SY; Sohn KM; Ryu JY; Yoon YR; Shin JG; Kim JW
    Ther Drug Monit; 2006 Jun; 28(3):382-7. PubMed ID: 16778723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population.
    Cai WM; Chen B; Zhang WX
    Clin Pharmacol Ther; 2007 Jan; 81(1):95-8. PubMed ID: 17186005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population.
    Tateishi T; Chida M; Ariyoshi N; Mizorogi Y; Kamataki T; Kobayashi S
    Clin Pharmacol Ther; 1999 May; 65(5):570-5. PubMed ID: 10340923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype and allele frequency of CYP2D6 in Tamilian population.
    Adithan C; Gerard N; Naveen AT; Koumaravelou K; Shashindran CH; Krishnamoorthy R
    Eur J Clin Pharmacol; 2003 Oct; 59(7):517-20. PubMed ID: 12942225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population.
    Kiyotani K; Shimizu M; Kumai T; Kamataki T; Kobayashi S; Yamazaki H
    Eur J Clin Pharmacol; 2010 Oct; 66(10):1065-8. PubMed ID: 20700584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.
    Veiga MI; Asimus S; Ferreira PE; Martins JP; Cavaco I; Ribeiro V; Hai TN; Petzold MG; Björkman A; Ashton M; Gil JP
    Eur J Clin Pharmacol; 2009 Apr; 65(4):355-63. PubMed ID: 18979093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.